Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Orthopaedica Belgica|August 6, 2026
Outcomes of hemicortical resection and reconstruction with liquid nitrogen-treated autograft for high-grade sarcomas: A retrospective case seriesF A Janjua, H U Arshad, M Osama, et al.
Journal of Community Genetics|March 4, 2020
How genomic information is accessed in clinical practice: an electronic survey of UK general practitionersW R H Evans, J Tranter, I Rafi, et al.
Journal of Community Genetics|May 30, 2020
The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunitiesI Rafi, I Crinson, M Dawes, et al.
British Journal of Cancer|March 10, 1999
A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administrationD I Jodrell, A Bowman, R Rye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 daysA N Hughes, I Rafi, M J Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusionI Rafi, G A Taylor, J A Calvete, et al.
Public Health Genomics|February 1, 2013
Stratified cancer screening: the practicalities of implementationT Dent, J Jbilou, I Rafi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumorsI Rafi, A V Boddy, J A Calvete, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|April 13, 2022
Evaluation of in vitro anticancer potential of pharmacological ethanolic plant extracts Acacia modesta and Opuntia monocantha against liver cancer cellsF Abid, M Saleem, T Leghari, et al.
Pageof 1